| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.06 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.058 | 0.06 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.33 | 0.06 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |